Farabi Pharmaceutical (XTEH:DFRB1) Research & Development: IRR Mil (TTM As of . 20)


What is Farabi Pharmaceutical Research & Development?

Farabi Pharmaceutical XTEH:DFRB1 Research & Development is IRR Mil as of . 20.

Research & Development is the aggregate amount of research and development expenses during the year. Farabi Pharmaceutical's Research & Development for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Farabi Pharmaceutical  (XTEH:DFRB1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Farabi Pharmaceutical Research & Development Related Terms

Farabi Pharmaceutical Research & Development Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Research & Development Chart

Farabi Pharmaceutical Annual Data
Trend
Research & Development

Farabi Pharmaceutical Quarterly Data
Research & Development

Farabi Pharmaceutical Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of IRR Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Research & Development of IRR Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Research & Development too high?
Farabi Pharmaceutical's current Research & Development is IRR Mil.
How does Farabi Pharmaceutical's Research & Development compare to IMNPQ and INNV?
Farabi Pharmaceutical's Research & Development of IRR Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Research & Development is IRR Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Research & Development of IRR Mil. The current Research & Development is IRR Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Research & Development is IRR Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.